QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
SV investment has resulted in the approval of 24 novel therapeutics
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
Merck to Acquire Caraway Therapeutics, Inc.
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group
- 8 February 2022Portfolio NewsLeiters Announces Facility Acquisition to Increase Capacity, Accommodate Growth and Expand Portfolio
- 8 December 2021Portfolio NewsCentauri Health Solutions Adds Clinical Data Exchange Capabilities with Acquisition of Secure Exchange Solutions
- 9 November 2021Portfolio NewsWelsh, Carson, Anderson & Stowe Acquires Majority Stake in Leiters
- 29 October 2021Portfolio NewsBioventus Completes the Acquisition of Misonix
- 19 August 2021Portfolio NewsSV Health Investors Announces Three Realizations in its Growth Equity Portfolio
- Video3 August 2021SV NewsPaul LaViolette describes SV's investment focus
- 29 July 2021Portfolio NewsWellSky® to Acquire Healthify to Enhance Social Services Care Coordination Across the Continuum
- 29 July 2021Portfolio NewsBioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire Misonix
- 16 June 2021Portfolio NewsVeranex Announces Investment From Summit Partners to Form Comprehensive Concept-to-Commercialization Medtech Services Company
- 22 March 2021Portfolio NewsEvidation Raises $153M to Scale Virtual Health Capabilities of Achievement™ Platform
- 18 March 2021Portfolio NewsWellspring Capital Management Recapitalizes HealthPRO Heritage
- 8 February 2021SV NewsThe Annual Healthcare Growth Update